Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Counterpath Corp (CPAH)

Counterpath Corp (CPAH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.48 +0.01 (+0.29%) 02/26/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.48 unch (unch) -
Cash Flow for Fri, Feb 26th, 2021

Fiscal Year End Date: 04/30

(Values in U.S. thousands)
  04-2020 04-2019 04-2018 04-2017 04-2016
Cash Flows From Operating Activities
Net Income -1,097 -5,013 -3,221 -2,459 -2,692
Depreciation Amortization 73 106 114 114 199
Accounts receivable -826 550 -1,376 1,076 96
Other Working Capital -176 270 -977 1,364 -301
Other Operating Activity 1,716 645 3,033 -798 591
Operating Cash Flow $-310 $-3,443 $-2,427 $-703 $-2,106
Cash Flows From Investing Activities
PPE Investments -120 -40 -100 -100 -28
Purchase Sale Intangibles -6 -10 -25 -28 -14
Other Investing Activity -5 -10 -25 -28 -14
Investing Cash Flow $-126 $-50 $-125 $-128 $-41
Cash Flows From Financing Activities
Debt Issued 1,000 3,000 N/A N/A N/A
Common Stock Issued 17 23 2,903 899 1,521
Common Stock Repurchased N/A N/A -33 -133 -39
Financing Cash Flow $1,017 $3,023 $2,870 $766 $1,482
Exchange Rate Effect -10 -16 -40 -24 -27
Beginning Cash Position 1,863 2,349 2,071 2,160 2,852
End Cash Position 2,433 1,863 2,349 2,071 2,160
Net Cash Flow $571 $-486 $278 $-89 $-693
Free Cash Flow
Operating Cash Flow -310 -3,443 -2,427 -703 -2,106
Capital Expenditure -120 -40 -100 -100 -28
Free Cash Flow -431 -3,484 -2,527 -803 -2,134
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective